摘要
卵巢切除为乳腺癌的内分泌治疗奠定了理论基础，寻找更有效。更安全的治疗药物愈加显得重要。本文就乳腺癌内分泌治疗的各类药物的研究进展作一综述。
参考文献3
-
1M. Dowsett,R. C. Coombes. Second generation aromatase inhibitor — 4-hydroxyandrostenedione[J] 1994,Breast Cancer Research and Treatment(1):81～87
-
2Paul V. Plourde M.D.,Martin Dyroff Ph.D,Michael Dukes Ph.D.. Arimidex?: A potent and selective fourth-generation aromatase inhibitor[J] 1994,Breast Cancer Research and Treatment(1):103～111
-
3Winrich Rauschning,Kathleen I. Pritchard. Droloxifene, a new antiestrogen: Its role in metastatic breast cancer[J] 1994,Breast Cancer Research and Treatment(1):83～94
同被引文献24
-
1曹明智,徐卓玉,刘铮,刘国津.三苯氧胺的可能副作用──卵巢囊肿[J].中华肿瘤防治杂志,1994,10(2):143-143. 被引量：1
-
2李振.恶性肿瘤的化学治疗与免疫治疗[M].北京:人民卫生出版社,1994.289.
-
3ElliSton JF et al. Mol Cell Biol, 1990; 10: 6607- 6612.
-
4alker RA et al. Cancer Metastasis Rev, 1997;16:5 - 27.
-
5Jesen EV, Smith S, Desombre ER. Hormone dependency in breast cancer[J ]. J Steroid Biochem,1976,7:911.
-
6Horwitz KB, Tung L, Takirnoto GS. Novel mechanisms of antiprogestin action [ J ]. Acto Oncol, 1996,35 : 129.
-
7Huovinen R, Warri A, Collan Y. Mitotic activity, apopotosis and TRPM- 2 mRNA expression in DMBA - Induced rat marrmaary carcinoma treated with anti- estrogen torenalfene[J ]. Int J Cancer, 1993,21,55(4) :685.
-
8Katase K.Cancer,1998,84(9):1698—1703.
-
9Hard GC, latropoulos MJ,Jordan K,et al. Major difference in the hepa to sarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl: CD(BR)rats[J]. Cancer Res, 1993,53(19) :4534.
-
10Rubens RD. Advanced Breast Cancer: Reassessing Hormonmal Therapy [ M ]. London, NewYork: Parthenon Publishing, 1996: 21 - 30.
-
1徐兵河,孙燕.乳腺癌内分泌治疗新药来曲唑研究进展[J].实用癌症杂志,2000,15(3):333-335. 被引量：18
-
2张骁.前列腺癌治疗药物研究进展[J].中国制药信息,2002,18(5):19-21.
-
3李斌,郑艳波,李良,甄永苏.基于抗体和配体的肿瘤靶向肽药物研究进展[J].中国医药生物技术,2014,9(4):294-299.
-
4刘宏本,马培奇.肝癌治疗药物研究进展[J].中国制药信息,2003,19(10):21-25. 被引量：1
-
5郭伟,王建华.食管癌术前放化疗及分子靶向药物研究进展[J].肿瘤基础与临床,2012,25(6):546-549. 被引量：2
-
6陈楠,江静,李小平,屠铮,魏丽惠.宫颈癌分子靶向治疗药物研究进展[J].中国妇产科临床杂志,2010,11(1):68-70. 被引量：3
-
7彭芳.乳腺癌的靶向治疗药物研究进展[J].现代中西医结合杂志,2016,25(14):1586-1588. 被引量：6
-
8林燕,陶红慧,严楚顺,翁乐瑾,戴佳琳.他莫昔芬与托瑞米芬治疗乳腺癌的经济学分析[J].中国医院用药评价与分析,2012,12(4):330-332. 被引量：8
-
9周辛波,肖典.临床在研的膀胱癌治疗药物研究进展[J].临床药物治疗杂志,2016,14(6):91-92. 被引量：4
-
10李梅.HER-2阳性乳腺癌靶向治疗药物研究进展[J].实用医药杂志,2012,29(8):752-754. 被引量：5
